Banque Pictet & Cie Sa Tg Therapeutics, Inc. Transaction History
Banque Pictet & Cie Sa
- $14.2 Billion
- Q2 2025
A detailed history of Banque Pictet & Cie Sa transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Banque Pictet & Cie Sa holds 12,324 shares of TGTX stock, worth $334,226. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,324
Previous 13,151
6.29%
Holding current value
$334,226
Previous $518,000
14.48%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TGTX
# of Institutions
413Shares Held
87.8MCall Options Held
2.36MPut Options Held
1.96M-
Vanguard Group Inc Valley Forge, PA15.8MShares$429 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$309 Million0.0% of portfolio
-
State Street Corp Boston, MA7.43MShares$202 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.49MShares$94.7 Million0.01% of portfolio
-
Clearbridge Investments, LLC New York, NY3.05MShares$82.8 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $3.94B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...